Please login to the form below

Not currently logged in
Email:
Password:

Hay fever sufferers risking health

Hay sufferers across the country are risking their health by taking the wrong medicines for their conditions and not seeking professional medical advice
Hay sufferers across the country are risking their health by taking the wrong medicines for their conditions and not seeking professional medical advice.

According to a new survey by the Royal Pharmaceutical Society of Great Britain (RPSGB), over five million hay fever sufferers could be taking inappropriate medicines. It also showed that 73 per cent of people who experience symptoms similar to that of hay fever do not visit a healthcare provider to receive advice.

David Pruce, RPSGB director of practice and quality improvement, said that the number of people that do not seek advice about their symptoms was 'surprising'.

Pruce said: "The survey results clearly demonstrate the impacts a condition like hay fever can have on peoples' lives, with millions suffering unnecessarily. Pharmacists are highly trained health professionals and experts in medicines ñ they can play a significant role in the management of allergies including hay fever."

Allergic rhinitis, more commonly known as hay fever, becomes prevalent during the summer period affects close to 13 million people across the country. The study, which was commissioned by the RPSGB, revealed that 29 per cent of people find it difficult to concentrate and 14 per cent said hay fever symptoms impaired their ability to read. These findings could have direct implications for school, college and university students who sit exams during the summer months.

14th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics